STOCK TITAN

BDC Form 144 Discloses Restricted Stock Vesting and Planned Sale of 3,800 Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Belden Inc. filed a Form 144 reporting a proposed sale of 3,800 common shares through Fidelity Brokerage Services with an aggregate market value of $483,664.00, and identifies the NYSE as the exchange for an approximate sale date of 09/04/2025. The shares were acquired on 08/30/2025 upon restricted stock vesting and the payment type is listed as compensation. The filing also discloses two recent sales by the same person: 296 shares on 06/25/2025 for $33,838.72 and 297 shares on 09/03/2025 for $37,454.67. The Form includes the standard representation that the seller does not possess undisclosed material adverse information. This notice documents insider sales and compliance with Rule 144 disclosure requirements.

Positive

  • Compliance disclosure completed under Rule 144, showing transparency about insider sales
  • Brokered sale via Fidelity and trading on the NYSE, indicating standard market execution

Negative

  • Insider selling of 3,800 shares valued at $483,664 is disclosed
  • Additional small sales in the past three months (296 and 297 shares) were also reported

Insights

TL;DR: Routine Rule 144 notice for restricted stock vesting and subsequent planned sale; disclosure aligns with regulatory obligations.

The filing documents a proposed sale of 3,800 shares following restricted stock vesting, with sales routed through a registered broker and the NYSE. The amounts and dates are explicit and consistent with Rule 144 reporting requirements. Recent small-volume disposals (296 and 297 shares) are disclosed for the past three months. No material nonpublic information is claimed. From a compliance perspective this is a standard insider sale notice and appears procedurally complete based on provided fields.

TL;DR: Insider sale is disclosed but size is negligible relative to outstanding shares, so market impact is likely immaterial.

The aggregate value of the proposed sale is $483,664 while the issuer reports 39,619,837 shares outstanding, indicating the transaction represents a very small fraction of the float. Two small prior disposals are noted in the three-month window. There are no earnings, liquidity, or debt items in this filing to change a valuation view. This disclosure informs investors of insider activity but does not, by itself, signal a material corporate development.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Belden Inc. (BDC) report on Form 144?

The filing reports a proposed sale of 3,800 common shares with an aggregate market value of $483,664.00, to be sold on or about 09/04/2025 on the NYSE.

How were the 3,800 shares acquired?

The shares were acquired on 08/30/2025 via restricted stock vesting and the consideration is listed as compensation.

Were there other recent sales by the same person?

Yes. The filer sold 296 shares on 06/25/2025 for $33,838.72 and 297 shares on 09/03/2025 for $37,454.67.

Does the filing indicate undisclosed material information?

The signer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.

How large is the proposed sale relative to shares outstanding?

The issuer lists 39,619,837 shares outstanding; the proposed sale of 3,800 shares represents a very small percentage of that total.